205 related articles for article (PubMed ID: 37515398)
1. Single-cell RNA sequencing identifies macrophage signatures correlated with clinical features and tumour microenvironment in meningiomas.
Zhang X
IET Syst Biol; 2023 Oct; 17(5):259-270. PubMed ID: 37515398
[TBL] [Abstract][Full Text] [Related]
2. Decoding meningioma heterogeneity and neoplastic cell-macrophage interaction through single-cell transcriptome profiling across pathological grades.
Fan H; Song L; Fan J; Ma J; Li X; Zhang J; Hu J; Wu Z; Zhang D; Wang L
J Transl Med; 2023 Oct; 21(1):751. PubMed ID: 37880655
[TBL] [Abstract][Full Text] [Related]
3. Intracranial meningiomas, the VEGF-A pathway, and peritumoral brain oedema.
Nassehi D
Dan Med J; 2013 Apr; 60(4):B4626. PubMed ID: 23651727
[TBL] [Abstract][Full Text] [Related]
4. DNA methylation-based classification and grading system for meningioma: a multicentre, retrospective analysis.
Sahm F; Schrimpf D; Stichel D; Jones DTW; Hielscher T; Schefzyk S; Okonechnikov K; Koelsche C; Reuss DE; Capper D; Sturm D; Wirsching HG; Berghoff AS; Baumgarten P; Kratz A; Huang K; Wefers AK; Hovestadt V; Sill M; Ellis HP; Kurian KM; Okuducu AF; Jungk C; Drueschler K; Schick M; Bewerunge-Hudler M; Mawrin C; Seiz-Rosenhagen M; Ketter R; Simon M; Westphal M; Lamszus K; Becker A; Koch A; Schittenhelm J; Rushing EJ; Collins VP; Brehmer S; Chavez L; Platten M; Hänggi D; Unterberg A; Paulus W; Wick W; Pfister SM; Mittelbronn M; Preusser M; Herold-Mende C; Weller M; von Deimling A
Lancet Oncol; 2017 May; 18(5):682-694. PubMed ID: 28314689
[TBL] [Abstract][Full Text] [Related]
5. Transcriptome signatures associated with meningioma progression.
Viaene AN; Zhang B; Martinez-Lage M; Xiang C; Tosi U; Thawani JP; Gungor B; Zhu Y; Roccograndi L; Zhang L; Bailey RL; Storm PB; O'Rourke DM; Resnick AC; Grady MS; Dahmane N
Acta Neuropathol Commun; 2019 Apr; 7(1):67. PubMed ID: 31039818
[TBL] [Abstract][Full Text] [Related]
6. NF2 mutation status and tumor mutational burden correlate with immune cell infiltration in meningiomas.
Rutland JW; Gill CM; Loewenstern J; Arib H; Pain M; Umphlett M; Kinoshita Y; McBride RB; Bederson J; Donovan M; Sebra R; Shrivastava RK; Fowkes M
Cancer Immunol Immunother; 2021 Jan; 70(1):169-176. PubMed ID: 32661686
[TBL] [Abstract][Full Text] [Related]
7. Genomic and transcriptome analysis revealing an oncogenic functional module in meningiomas.
Chang X; Shi L; Gao F; Russin J; Zeng L; He S; Chen TC; Giannotta SL; Weisenberger DJ; Zada G; Wang K; Mack WJ
Neurosurg Focus; 2013 Dec; 35(6):E3. PubMed ID: 24289128
[TBL] [Abstract][Full Text] [Related]
8. DNA microarray analysis identifies CKS2 and LEPR as potential markers of meningioma recurrence.
Menghi F; Orzan FN; Eoli M; Farinotti M; Maderna E; Pisati F; Bianchessi D; Valletta L; Lodrini S; Galli G; Anghileri E; Pellegatta S; Pollo B; Finocchiaro G
Oncologist; 2011; 16(10):1440-50. PubMed ID: 21948653
[TBL] [Abstract][Full Text] [Related]
9. Novel Human Meningioma Organoids Recapitulate the Aggressiveness of the Initiating Cell Subpopulations Identified by ScRNA-Seq.
Huang M; Xu S; Li Y; Shang L; Zhan X; Qin C; Su J; Zhao Z; He Y; Qin L; Zhao W; Long W; Liu Q
Adv Sci (Weinh); 2023 May; 10(15):e2205525. PubMed ID: 36994665
[TBL] [Abstract][Full Text] [Related]
10. Integrated Transcriptomic Analysis Reveals the Molecular Mechanism of Meningiomas by Weighted Gene Coexpression Network Analysis.
Yang B; Wei S; Ma YB; Chu SH
Biomed Res Int; 2020; 2020():4927547. PubMed ID: 32596316
[TBL] [Abstract][Full Text] [Related]
11. Evidence of ubiquitous in vivo and in vitro expression of pro-apoptotic Smac/DIABLO protein in meningioma cell lines.
Pfister C; Ritz R; Endemann E; Schittenhelm J; Bornemann A; Tatagiba MS; Roser F
Oncol Rep; 2009 May; 21(5):1181-8. PubMed ID: 19360292
[TBL] [Abstract][Full Text] [Related]
12. Meningioma transcription factors link cell lineage with systemic metabolic cues.
Du Z; Brewster R; Merrill PH; Chmielecki J; Francis J; Aizer A; Abedalthagafi M; Sholl LM; Geffers L; Alexander B; Santagata S
Neuro Oncol; 2018 Sep; 20(10):1331-1343. PubMed ID: 29660031
[TBL] [Abstract][Full Text] [Related]
13. A Rapid Robust Method for Subgrouping Non-NF2 Meningiomas According to Genotype and Detection of Lower Levels of M2 Macrophages in
Adams CL; Ercolano E; Ferluga S; Sofela A; Dave F; Negroni C; Kurian KM; Hilton DA; Hanemann CO
Int J Mol Sci; 2020 Feb; 21(4):. PubMed ID: 32070062
[TBL] [Abstract][Full Text] [Related]
14. Meningiomas in patients with neurofibromatosis type 2 predominantly comprise 'immunogenic subtype' tumours characterised by macrophage infiltration.
Teranishi Y; Miyawaki S; Nakatochi M; Okano A; Ohara K; Hongo H; Ishigami D; Sakai Y; Shimada D; Takayanagi S; Ikemura M; Komura D; Katoh H; Mitsui J; Morishita S; Ushiku T; Ishikawa S; Nakatomi H; Saito N
Acta Neuropathol Commun; 2023 Sep; 11(1):156. PubMed ID: 37752594
[TBL] [Abstract][Full Text] [Related]
15. Microarray gene expression profiling in meningiomas: differential expression according to grade or histopathological subtype.
Fèvre-Montange M; Champier J; Durand A; Wierinckx A; Honnorat J; Guyotat J; Jouvet A
Int J Oncol; 2009 Dec; 35(6):1395-407. PubMed ID: 19885562
[TBL] [Abstract][Full Text] [Related]
16. Identification of the Key Immune Cells and Genes for the Diagnostics and Therapeutics of Meningioma.
Chen J; Hua L; Xu X; Jiapaer Z; Deng J; Wang D; Zhang L; Li G; Gong Y
World Neurosurg; 2023 Aug; 176():e501-e514. PubMed ID: 37263494
[TBL] [Abstract][Full Text] [Related]
17. M2-Macrophage-Derived Exosomes Promote Meningioma Progression through TGF-
Fu XH; Li JP; Li XY; Tan Y; Zhao M; Zhang SF; Wu XD; Xu JG
J Immunol Res; 2022; 2022():8326591. PubMed ID: 35637794
[TBL] [Abstract][Full Text] [Related]
18. Expression and prognostic impact of immune modulatory molecule PD-L1 in meningioma.
Han SJ; Reis G; Kohanbash G; Shrivastav S; Magill ST; Molinaro AM; McDermott MW; Theodosopoulos PV; Aghi MK; Berger MS; Butowski NA; Barani I; Phillips JJ; Perry A; Okada H
J Neurooncol; 2016 Dec; 130(3):543-552. PubMed ID: 27624915
[TBL] [Abstract][Full Text] [Related]
19. Posttranscriptional deregulation of signaling pathways in meningioma subtypes by differential expression of miRNAs.
Ludwig N; Kim YJ; Mueller SC; Backes C; Werner TV; Galata V; Sartorius E; Bohle RM; Keller A; Meese E
Neuro Oncol; 2015 Sep; 17(9):1250-60. PubMed ID: 25681310
[TBL] [Abstract][Full Text] [Related]
20. Expression of beta2 integrins and macrophage-associated antigens in meningeal tumours.
Mosnier JF; Perret AG; Scoazec JY; Brunon J
Virchows Arch; 2000 Feb; 436(2):131-7. PubMed ID: 10755603
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
